Cargando…
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed countries. Its frequency is increasing in the general population mostly due to the widespread occurrence of obesity and the metabolic syndrome. Although drugs and dietary supplements are viewed as a major cause...
Autores principales: | Rabinowich, Liane, Shibolet, Oren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529891/ https://www.ncbi.nlm.nih.gov/pubmed/26273591 http://dx.doi.org/10.1155/2015/168905 |
Ejemplares similares
-
Reply to: “Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!”
por: Rabinowich, Liane, et al.
Publicado: (2022) -
Clinical management of acute liver failure: Results of an international multi-center survey
por: Rabinowich, Liane, et al.
Publicado: (2016) -
Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022) -
Innate Lymphoid Cells: New Culprits of Alcohol-Associated Steatohepatitis
por: Choi, Sung Eun, et al.
Publicado: (2022) -
Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus
por: Bar, Nir, et al.
Publicado: (2022)